ANA
AIASTUI PUJANA
![Foto de ANA](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (13)
2023
-
Altered expression of proteins involved in metabolism in LGMDR1 muscle is lost in cell culture conditions
Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1
2021
-
Allosteric modulation of GSK‐3β as a new therapeutic approach in limb girdle muscular dystrophy R1 Calpain 3‐related
International Journal of Molecular Sciences, Vol. 22, Núm. 14
-
Patient-specific iPSC-derived cellular models of LGMDR1
Stem Cell Research, Vol. 53
2020
-
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease
Aging, Vol. 12, Núm. 17, pp. 16690-16708
-
Toxicity of necrostatin-1 in Parkinson’s disease models
Antioxidants, Vol. 9, Núm. 6, pp. 1-13
2019
-
Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients
Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481
2017
-
FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway
Expert Reviews in Molecular Medicine, Vol. 19
2016
-
Identification and Characterization of the Dermal Panniculus Carnosus Muscle Stem Cells
Stem Cell Reports, Vol. 7, Núm. 3, pp. 411-424
2015
-
Muscle wasting in myotonic dystrophies: A model of premature aging
Frontiers in Aging Neuroscience, Vol. 7, Núm. JUN
2014
-
G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy
Toxicology, Vol. 324, pp. 1-9
-
LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity
Human Molecular Genetics, Vol. 23, Núm. 25, pp. 1-18
-
Murine muscle engineered from dermal precursors: An in vitro model for skeletal muscle generation, degeneration, and fatty infiltration
Tissue Engineering - Part C: Methods, Vol. 20, Núm. 1, pp. 28-41
2013
-
In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs
Human Mutation, Vol. 34, Núm. 10, pp. 1387-1395